Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Hydantoin derivative anticonvulsant

Known as: Hydantoin 
National Institutes of Health

Related topics

Related topics

15 relations

Narrower (11)

AllantoinDantroleneDihydanEthotoin
Expand

Broader (4)

AnticonvulsantsHydantoinsImidazolesimidazoledione

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
The NEIL glycosylases remove oxidized guanine lesions from telomeric and promoter quadruplex DNA structures
G-quadruplex is a four-stranded G-rich DNA structure that is highly susceptible to oxidation. Despite the important roles that G… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2012
Highly Cited
2012
Hippocampal adult neurogenesis is maintained by Neil3-dependent repair of oxidative DNA lesions in neural progenitor cells.
Accumulation of oxidative DNA damage has been proposed as a potential cause of age-related cognitive decline. The major pathway… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2010
Highly Cited
2010
Mutation versus repair: NEIL1 removal of hydantoin lesions in single-stranded, bulge, bubble, and duplex DNA contexts.
Human DNA glycosylase NEIL1 exhibits a superior ability to remove oxidized guanine lesions guanidinohydantoin (Gh) and… 
2001
2001
Cloning and characterization of genes from Agrobacterium sp. IP I-671 involved in hydantoin degradation
Abstract. Cloning and sequencing of a 7.1 kb DNA fragment from Agrobacterium sp IP I-671 revealed seven open reading frames (ORFs… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2001
2001
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection.
A series of hydantoin derivatives has been discovered as highly potent nonpeptide antagonists for the human CCR5 receptor. The… 
2000
2000
Hydantoin racemase from Arthrobacter aurescens DSM 3747: heterologous expression, purification and characterization.
In Arthrobacter aurescens DSM 3747 three enzymes are involved in the complete conversion of slowly racemizing 5'-monosubstituted… 
1992
1992
Identification and sequencing of a gene encoding a hydantoin racemase from the native plasmid of Pseudomonas sp. strain NS671
DNA fragments containing the genes involved in the conversion of 5-substituted hydantoins to their corresponding L-amino acids… 
Review
1970
Review
1970
Malignant lymphoma associated with hydantoin drugs.
LYMPHADENOPATHY has been recognized as one of the less common side effects of the hydantoin drugs 1-3 for more than a quarter of… 
Highly Cited
1959
Highly Cited
1959
THE MECHANISM OF THE PAIN IN TRIGEMINAL NEURALGIA
Trigeminal neuralgia (tic douloureux) is characterized by brief paroxysms of pain limited to the facial distribution of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE